Erik L. Ridley and Philip Ward[email protected]AIRadNet broadens AI focus with acquisitions of Aidence, QuantibU.S. imaging services provider RadNet has acquired Dutch artificial intelligence (AI) software developers Aidence and Quantib in deals that the company hopes will enable wide-scale screening programs for lung and prostate cancer.January 23, 2022Page 1 of 1Top StoriesMolecular ImagingPET/CT could improve margin assessment for breast tumorsSpecimen PET/CT imaging outperforms routine intraoperative margin assessment in breast tumors.HomeOne conference, three lessonsRadiation Oncology/TherapySingle-fraction SBRT a valid option for localized prostate cancerClinical NewsWHO: Europe's healthcare systems face "permacrisis"MRIGerman MRI concept aims to transform pediatric imaging